The Revolutionary Biomedical Engineer that Grows Living Human Tissues for Transplants and Other Therapies
"Cells mediate our experience of life. Behind every sound, sight, touch, taste and smell is a corresponding set of cells that receive this information and interpret it for us."
Nina Tandon is changing medical science as we know it. As the CEO and co-founder of EpiBone, she is leading the charge of biology's industrial revolution by overseeing the world's first company growing living human bone for skeletal reconstruction. The benefits of this revolutionary stem cell technology, which has already been approved by the FDA, include simplified surgery, improved bone formation, and shorter recovery times for patients.
She is a TED senior fellow and she holds a Master's in Bioelectrical Engineering from MIT, a PhD in Biomedical Engineering, and a MBA from Columbia University.
She is a senior fellow at the Lab for Stem Cells and Tissue Engineering at Columbia, and currently serves as an adjunct professor of Electrical Engineering at Cooper Union. She is co-author of book Super Cells: Building with Biology and has been published in Nature Protocols and Lab on a Chip, and featured on CNN, in WIRED (who also named her one of their Innovation Fellows), The Guardian, and more.
Tandon was named a Global Thinker by Foreign Policy, one of Crain's New York Business 40 Under 40, World Economic Forum Tech Pioneer and one of Fast Company's Most Creative People in Business.